Table 1:

Patient characteristics, aneurysmal specifics, technical aspect of the procedure, and antiplatelet drug reactivity associated with any diffusion-positive lesion in patients undergoing endovascular coiling of unruptured intracranial aneurysms

CategoryaGrade 0 (n = 30)Grade I/II (n = 28)PuniPlogistic
SexMale (23, 39.7%)1211.956
Female (35, 60.3%)1817
Age (years)≤60 (35, 60.3%)2114.179
>60 (23, 39.7%)914
HTNYes (23, 39.7%)1112.789
DMYes (4, 6.9%)31.612
DyslipidemiaYes (11, 19.0%)47.325
CADYes (3, 5.2%)12.605
StrokeYes (6, 10.3%)15.097.998
StatinYes (11, 19.0%)56.744
AspirinYes (19, 32.8%)910.781
SmokingYes (15, 25.9%)78.767
Dome size<7 mm (39, 67.2%)2217.404
≥7 mm (19, 32.8%)811
Neck width<4 mm (32, 55.2%)1913.291
≥4 mm (26, 44.8%)1115
Multiplicity of the procedurebSingle (54, 93.1%)3024.048.072
Double (4, 6.9%)04
Procedural methodsSingle (16, 27.6%)c106.453
Double (18, 41.4%)c108
Stent (24, 31%)1014
Aspirin resistanceYes (9, 15.5%)36.290.720
Clopidogrel resistanceYes (23, 39.7%)1112.789.998
  • Note:—HTN indicates hypertension; DM, diabetes mellitus; CAD, coronary artery disease.

  • a (number, percent).

  • b Multiple procedures in a single session.

  • c Single or double microcatheter technique, stent-assisted technique.